Meperidine versus valethamate bromide in shortening the duration of labor

Phase 1

Completed

• Conditions: Shortening the duration of labor; Reproductive Health and Childbirth - Childbirth and postnatal care; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12609000153213
• Lead Sponsor: Dr Sefa Kelekci

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-03-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 39

Inclusion Criteria

otherwise healthy nulliparous women undergoing labor induction between 18 and 30 years old with a term singleton pregnancy, vertex presentation

Exclusion Criteria

spontaneous labor, estimated fetal weight > 4000 g, suspicion of cephalopelvic disproportion (CPD), evidence of fetal distress, meperidine or valethamate bromide allergy, previous uterine surgery, active vaginal bleeding, placenta praevia, and use of any kind of analgesia prior randomization.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean injection-delivery interval, monitored by the author who was blind to the medication.[from the time of beginning of the intervention to the time of the expulsion of the fetus.]

Secondary Outcome Measures

Name	Time	Method
maternal adverse effects, monitored by the author who was blind to the medication.[Monitored constantly throughout the birth after the allocated treatment has been injected into the participant.];fetal adverse effects, monitored by the author who was blind to the medication.[Immediately after delivery .]